OTLK Outlook Therapeutics, Inc.

Oncobiologics Inc is a clinical-stage biopharmaceutical company. It is engaged in identifying, developing, manufacturing and commercializing complex biosimilar therapeutics in the disease areas of immunology and oncology.

$1.51
As of 11/30/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/14/2016
Outstanding shares:  175,341,173
Average volume:  1,968,449
Market cap:   $240,217,407
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    69012T206
ISIN:        US69012T2069
Sedol:      BJ4KCD5

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   19.73
PS ratio:   0.00
Return on equity:   -354.11%
Net income %:   0.00%